Choroby przenoszone drogą płciową
Diagnostyka i diagnoza

Diagnostyka chorób przenoszonych drogą płciową (STD) opiera się na kompleksowym podejściu, które zaczyna się od szczegółowego wywiadu seksualnego i badania fizykalnego, a następnie wykorzystuje różnorodne metody laboratoryjne, w tym testy serologiczne, analizy moczu, wymazy oraz nowoczesne testy molekularne typu NAAT. Testy te charakteryzują się wysoką czułością i swoistością, co jest szczególnie istotne w wykrywaniu bezobjawowych infekcji, takich jak Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum (kiła), HIV, wirusowe zapalenie wątroby typu B i C, Trichomonas vaginalis oraz wirusy HSV i HPV. Zalecenia przesiewowe obejmują coroczne badania u kobiet aktywnych seksualnie poniżej 25 roku życia, badania kobiet w ciąży oraz mężczyzn mających kontakty seksualne z mężczyznami (MSM), z częstotliwością badań dostosowaną do indywidualnego ryzyka. W diagnostyce kiły stosuje się dwuetapowy algorytm serologiczny (testy treponemalne i niekrętkowe), a w przypadku rzeżączki ważne jest utrzymanie zdolności hodowli do oceny oporności na antybiotyki.

Diagnostyka chorób przenoszonych drogą płciową

Choroby przenoszone drogą płciową (STD) stanowią istotny problem zdrowia publicznego na całym świecie. Wczesna i precyzyjna diagnostyka tych infekcji jest kluczowa nie tylko dla skutecznego leczenia, ale również dla zapobiegania ich dalszemu rozprzestrzenianiu się. Proces diagnostyczny rozpoczyna się od wywiadu dotyczącego historii seksualnej i aktualnych objawów, jednak należy pamiętać, że wiele infekcji przenoszonych drogą płciową przebiega bezobjawowo, co zwiększa ryzyko nieświadomego przekazywania ich partnerom seksualnym12.

Znaczenie diagnostyki STD

Właściwa diagnostyka chorób przenoszonych drogą płciową ma podstawowe znaczenie z kilku powodów. Przede wszystkim pozwala na wczesne rozpoczęcie leczenia, co zmniejsza ryzyko długoterminowych powikłań, takich jak utrata wzroku, uszkodzenie narządów, niepłodność, a w niektórych przypadkach nawet śmierć3. Jest to szczególnie istotne, ponieważ nieleczone choroby przenoszone drogą płciową mogą prowadzić do poważnych konsekwencji zdrowotnych, a niektóre z nich, jak HIV czy wirusowe zapalenie wątroby typu B, są chorobami przewlekłymi4.

Diagnostyka chorób przenoszonych drogą płciową umożliwia również identyfikację i leczenie zakażonych osób, zanim rozwiną się u nich powikłania, a także identyfikację, badanie i leczenie ich partnerów seksualnych w celu zapobiegania transmisji i ponownym zakażeniom5. Jest to szczególnie ważne, ponieważ wiele osób zakażonych nie wykazuje żadnych objawów, co zwiększa ryzyko powikłań i utrzymującej się transmisji w społeczeństwie5.

Badanie lekarskie i wywiad

Diagnostyka chorób przenoszonych drogą płciową rozpoczyna się od dokładnego wywiadu medycznego i seksualnego. Lekarz przeprowadza szczegółową rozmowę na temat objawów, historii seksualnej i czynników ryzyka1. Istotne jest, aby pacjent był szczery i otwarty podczas tej rozmowy, co pomoże personelowi medycznemu w doborze odpowiednich testów diagnostycznych6.

Następnie przeprowadzane jest badanie fizykalne lub ginekologiczne w celu poszukiwania oznak infekcji, takich jak wysypka, brodawki lub wydzielina1. Badanie to może obejmować ocenę zewnętrznych narządów płciowych, badanie ginekologiczne u kobiet lub badanie prostaty i jąder u mężczyzn7.

Warto podkreślić, że badanie lekarskie i wywiad stanowią jedynie pierwszy etap diagnostyki i często wymagają potwierdzenia za pomocą specjalistycznych testów laboratoryjnych8.

Metody diagnostyczne STD

Istnieje kilka głównych metod diagnozowania chorób przenoszonych drogą płciową. Każda z nich ma swoje zalety i ograniczenia, a wybór konkretnej metody zależy od rodzaju podejrzewanej infekcji, dostępności testów i preferencji pacjenta9.

Badania krwi

Badania krwi są często wykorzystywane do diagnozowania pewnych chorób przenoszonych drogą płciową, szczególnie tych wywoływanych przez wirusy. Testy te mogą wykryć obecność przeciwciał lub antygenów charakterystycznych dla określonych patogenów1.

Do chorób diagnozowanych za pomocą badań krwi należą:

  • HIV – testy krwi są standardową metodą wykrywania przeciwciał lub antygenów HIV110
  • Kiła – zarówno wczesne, jak i późne stadia kiły mogą być diagnozowane za pomocą testów krwi1
  • Wirusowe zapalenie wątroby typu B i C – badania krwi mogą wykryć obecność antygenów i przeciwciał charakterystycznych dla tych wirusów1011
  • Opryszczka (HSV) – specyficzne testy serologiczne mogą wskazać na przebytą lub aktualną infekcję HSV12

Należy podkreślić, że testy serologiczne w kierunku kiły mogą wykorzystywać różne algorytmy diagnostyczne, w tym tzw. algorytm standardowy lub odwrócony, które obejmują testy początkowe i potwierdzające dla każdego wstępnie pozytywnego wyniku13.

Badania moczu

Analiza moczu jest kolejną ważną metodą diagnozowania chorób przenoszonych drogą płciową. Jest to nieinwazyjna metoda, która może być preferowana przez pacjentów i jest stosunkowo łatwa do przeprowadzenia1.

Choroby, które można diagnozować za pomocą badań moczu, to:

  • Chlamydia – NAAT (testy amplifikacji kwasów nukleinowych) wykonywane z próbek moczu mają wysoką czułość i swoistość14
  • Rzeżączka – podobnie jak w przypadku chlamydii, próbki moczu mogą być badane za pomocą NAAT14
  • Rzęsistek pochwowy (Trichomonas vaginalis) – niektóre testy molekularne umożliwiają wykrycie tego pierwotniaka w moczu15

Przed pobraniem próbki moczu pacjent nie powinien oddawać moczu przez co najmniej godzinę, a kobiety nie powinny oczyszczać okolic sromu przed oddaniem próbki15.

Badania wymazu

Badania wymazu polegają na pobraniu próbek z potencjalnych miejsc infekcji, takich jak pochwa, szyjka macicy, cewka moczowa, gardło lub odbyt. Próbki te mogą być następnie badane za pomocą różnych metod, w tym mikroskopii, hodowli bakteryjnej lub testów molekularnych16.

Do chorób diagnozowanych za pomocą wymazów należą:

  • Chlamydia – wymazy z szyjki macicy, cewki moczowej lub odbytu7
  • Rzeżączka – wymazy z szyjki macicy, cewki moczowej, gardła lub odbytu7
  • Rzęsistek pochwowy – wymazy z pochwy lub cewki moczowej17
  • Opryszczka – wymazy z aktywnych zmian skórnych7
  • HPV – wymazy z szyjki macicy (test Pap) lub innych miejsc infekcji18

W przypadku infekcji oportunistycznych, takich jak zakażenia Mycoplasma genitalium, Ureaplasma parvum, Ureaplasma urealyticum czy Mycoplasma hominis, również stosuje się badania wymazu17.

Testy molekularne

Testy molekularne, szczególnie testy amplifikacji kwasu nukleinowego (NAAT), zyskały w ostatnich latach ogromną popularność w diagnostyce chorób przenoszonych drogą płciową ze względu na ich wysoką czułość i swoistość19.

NAAT mają znacznie krótszy czas realizacji (mogą być łatwo zautomatyzowane, a czas do uzyskania wyniku jest znacznie krótszy niż w przypadku tradycyjnych podejść), umożliwiają wykrywanie organizmów, których nie można hodować w kulturach, i mają znacznie wyższą czułość (dramatycznie istotna zaleta w przypadku bezobjawowych infekcji, gdzie obciążenie organizmów jest niskie)19.

Testy molekularne są szczególnie przydatne w diagnozowaniu:

  • Chlamydia trachomatis – w tym wariantów L1, L2 i L3, które powodują ziarniniak weneryczny17
  • Neisseria gonorrhoeae – wysokiego ryzyka rzeżączki14
  • Trichomonas vaginalis – rzęsistkowicy15
  • Mycoplasma genitalium i innych mykoplazm moczopłciowych17
  • Herpes simplex virus (HSV-1 i HSV-2)17

Warto zauważyć, że metody molekularne pozwalają również na wykrywanie współistniejących zakażeń (koinfekcji), co jest istotne w ustalaniu kompleksowego planu leczenia17.

Diagnostyka poszczególnych chorób przenoszonych drogą płciową

Każda choroba przenoszona drogą płciową wymaga specyficznego podejścia diagnostycznego. Poniżej przedstawiono metody diagnostyczne stosowane w przypadku najczęstszych STD.

Diagnostyka chlamydiozy

Chlamydia trachomatis jest jedną z najczęstszych bakteryjnych chorób przenoszonych drogą płciową. Do jej diagnozowania stosuje się przede wszystkim testy NAAT, które charakteryzują się wysoką czułością i swoistością14.

Zalecenia dotyczące badań przesiewowych w kierunku chlamydii obejmują:

  • Coroczne badania wszystkich aktywnych seksualnie kobiet poniżej 25 roku życia20
  • Badania aktywnych seksualnie kobiet powyżej 25 roku życia, jeśli są w grupie zwiększonego ryzyka20
  • Badania wszystkich kobiet w ciąży poniżej 25 roku życia oraz kobiet w ciąży powyżej 25 roku życia, jeśli są w grupie zwiększonego ryzyka20
  • Ponowne badanie około 3 miesięcy po leczeniu20

Ponadto, w przypadku kobiet można rozważyć badanie w kierunku chlamydii z próbek z odbytu na podstawie zgłaszanych zachowań seksualnych i ekspozycji, poprzez wspólną decyzję kliniczną między pacjentem a lekarzem20.

Diagnostyka rzeżączki

Neisseria gonorrhoeae jest bakterią wywołującą rzeżączkę. Podobnie jak w przypadku chlamydii, do jej diagnozowania najczęściej stosuje się testy NAAT14.

Zalecenia dotyczące badań przesiewowych w kierunku rzeżączki są podobne do tych dla chlamydii i obejmują:

  • Coroczne badania wszystkich aktywnych seksualnie kobiet poniżej 25 roku życia21
  • Badania aktywnych seksualnie kobiet powyżej 25 roku życia, jeśli mają nowych lub wielu partnerów seksualnych lub partnera z STI21
  • Badania kobiet w ciąży we wczesnej fazie ciąży21

W przypadku mężczyzn mających kontakty seksualne z mężczyznami (MSM) zaleca się badania co najmniej raz w roku w miejscach kontaktu (cewka moczowa, odbyt) niezależnie od stosowania prezerwatyw, a co 3-6 miesięcy, jeśli występuje zwiększone ryzyko20.

Warto również zauważyć, że oporność na środki przeciwdrobnoustrojowe u gonokoków jest poważnym problemem na całym świecie, i ponieważ hodowla jest jedyną metodą umożliwiającą badanie wrażliwości na środki przeciwdrobnoustrojowe, kluczowe jest utrzymanie i, w razie potrzeby, wzmocnienie zdolności hodowli we wszystkich krajach22.

Diagnostyka kiły

Kiła, wywoływana przez bakterię Treponema pallidum, jest diagnozowana głównie za pomocą testów serologicznych, które wykrywają przeciwciała przeciwko tej bakterii23.

Standardowy protokół diagnostyczny obejmuje dwuetapowy algorytm badań serologicznych:

  • Testy krętkowe (treponemal) – wykrywają przeciwciała specyficzne dla krętka bladego
  • Testy niekrętkowe (non-treponemal) – wykrywają przeciwciała skierowane przeciwko lipidom uwolnionym z uszkodzonych komórek13

Zalecenia dotyczące badań przesiewowych w kierunku kiły obejmują:

  • Badania wszystkich kobiet w ciąży podczas pierwszej wizyty prenatalnej22
  • Coroczne badania mężczyzn mających kontakty seksualne z mężczyznami20
  • Badania osób z HIV23

Szybkie testy w kierunku kiły są dostępne i mogą być wykorzystywane w ramach badań przesiewowych, szczególnie w warunkach ograniczonych zasobów24.

Diagnostyka HIV

Wirus HIV (Human Immunodeficiency Virus) jest diagnozowany za pomocą testów wykrywających przeciwciała przeciwko wirusowi, antygeny wirusa lub materiał genetyczny wirusa1.

Zalecenia dotyczące badań przesiewowych w kierunku HIV obejmują:

  • Badania wszystkich osób w wieku 15-65 lat przynajmniej raz w życiu1
  • Badania wszystkich kobiet w ciąży podczas pierwszej wizyty prenatalnej1
  • Badania osób z innymi STD23
  • Coroczne badania mężczyzn mających kontakty seksualne z mężczyznami, jeśli status HIV jest nieznany lub negatywny, a pacjent lub jego partner(zy) seksualni mieli więcej niż jednego partnera seksualnego od czasu ostatniego testu na HIV20

Dostępne są również szybkie testy w kierunku HIV, które mogą dostarczyć wyników w ciągu kilkunastu minut24.

Diagnostyka rzęsistkowicy

Rzęsistek pochwowy (Trichomonas vaginalis) jest pierwotniakiem wywołującym rzęsistkowicę. Do jego diagnozowania stosuje się zarówno tradycyjne metody mikroskopowe, jak i nowsze testy molekularne15.

Zalecenia dotyczące badań przesiewowych w kierunku rzęsistkowicy obejmują:

  • Rozważenie badań u kobiet korzystających z opieki w placówkach o wysokiej częstości występowania (np. kliniki STI i zakłady karne) oraz u bezobjawowych kobiet z wysokim ryzykiem infekcji20
  • Badania osób z innymi STD23

Nowoczesne testy NAAT mają wysoką czułość i swoistość w diagnozowaniu rzęsistkowicy19.

Diagnostyka opryszczki narządów płciowych

Opryszczka narządów płciowych jest wywoływana przez wirusy HSV-1 i HSV-2 (Herpes Simplex Virus). Diagnoza opiera się na badaniu klinicznym, testach wirusologicznych i serologicznych13.

Do metod diagnostycznych należą:

  • PCR – badanie materiału genetycznego wirusa z wymazów z aktywnych zmian skórnych7
  • Testy serologiczne – wykrywające przeciwciała przeciwko HSV-1 i HSV-212

CDC stwierdza, że swoiste dla typu testy serologiczne HSV-2 są przydatne w następujących scenariuszach: nawracające lub nietypowe objawy lub zmiany genitalne z negatywnym wynikiem PCR lub hodowli HSV, kliniczna diagnoza opryszczki narządów płciowych bez potwierdzenia laboratoryjnego oraz gdy partner pacjenta ma opryszczkę narządów płciowych13.

Diagnostyka HPV

Wirus brodawczaka ludzkiego (HPV – Human Papillomavirus) jest najczęstszą chorobą przenoszoną drogą płciową na świecie. Diagnoza opiera się głównie na badaniach cytologicznych (test Pap) oraz testach molekularnych25.

Zalecenia dotyczące badań przesiewowych obejmują:

  • Badania cytologiczne (Pap) co 2-3 lata dla wszystkich kobiet powyżej 21 roku życia26
  • Test HPV zwykle nie jest oferowany kobietom poniżej 30 roku życia, ponieważ infekcje HPV, które ostatecznie samoistnie ustąpią, są tak powszechne w tej grupie wiekowej26

Regularne badania przesiewowe są kluczowe dla wczesnego wykrywania zmian przednowotworowych spowodowanych przez HPV, które mogą prowadzić do raka szyjki macicy25.

Badania przesiewowe i wskazania do testowania

Badania przesiewowe w kierunku chorób przenoszonych drogą płciową są zalecane dla różnych grup osób, nawet jeśli nie wykazują one objawów. Celem tych badań jest wczesne wykrycie i leczenie infekcji, zapobieganie powikłaniom oraz ograniczenie rozprzestrzeniania się tych chorób1.

Zalecenia dotyczące badań przesiewowych

Centra Kontroli i Zapobiegania Chorobom (CDC) oraz inne organizacje zdrowotne zalecają badania przesiewowe w kierunku chorób przenoszonych drogą płciową dla różnych grup osób:

  • Kobiety aktywne seksualnie poniżej 25 roku życia powinny być badane w kierunku chlamydii i rzeżączki co roku2021
  • Kobiety aktywne seksualnie powyżej 25 roku życia powinny być badane, jeśli są w grupie zwiększonego ryzyka (np. nowi lub liczni partnerzy seksualni)20
  • Wszystkie kobiety w ciąży powinny być badane w kierunku HIV, kiły, wirusowego zapalenia wątroby typu B i chlamydii na wczesnym etapie ciąży122
  • Mężczyźni mający kontakty seksualne z mężczyznami powinni być badani w kierunku chlamydii, rzeżączki, kiły i HIV co najmniej raz w roku, a częściej, jeśli są w grupie zwiększonego ryzyka2020
  • Osoby z HIV powinny być badane w kierunku STD podczas pierwszej oceny i co najmniej raz w roku później20
  • Wszyscy dorośli w wieku 18 lat i starsi powinni być przynajmniej raz badani w kierunku wirusowego zapalenia wątroby typu B, z testem obejmującym kilka różnych markerów wirusa12

Ponadto, eksperci zalecają badanie w kierunku HIV co najmniej raz jako rutynową część opieki zdrowotnej dla osób w wieku od 15 do 65 lat12.

Grupy ryzyka i wskazania do testowania

Istnieją określone grupy osób, które są bardziej narażone na choroby przenoszone drogą płciową i dla których regularne badania są szczególnie ważne:

  • Osoby młode poniżej 25 roku życia – prawie 50% nowych zakażeń STI występuje u osób w wieku 15-24 lat21
  • Osoby z wieloma partnerami seksualnymi27
  • Mężczyźni mający kontakty seksualne z mężczyznami20
  • Osoby, których partner ma STD12
  • Osoby z HIV1
  • Kobiety w ciąży1
  • Osoby, które miały niezabezpieczony stosunek seksualny27
  • Osoby, które przypadkowo dzieliły igły z nieznaną osobą27

Ponadto, badania w kierunku STD są zalecane dla osób z objawami, takimi jak bolesne oddawanie moczu, ból podczas stosunku płciowego, wydzielina z pochwy lub krwawienie27.

Określenie częstotliwości badań

Częstotliwość badań w kierunku chorób przenoszonych drogą płciową zależy od indywidualnych czynników ryzyka i zaleceń lekarza12.

Ogólne wytyczne dotyczące częstotliwości badań obejmują:

  • Coroczne badania dla osób aktywnych seksualnie poniżej 25 roku życia20
  • Badania co 3-6 miesięcy dla osób z grupy zwiększonego ryzyka, takich jak MSM stosujący PrEP, z zakażeniem HIV lub jeśli oni lub ich partnerzy seksualni mają wielu partnerów20
  • Ponowne badanie około 3 miesięcy po leczeniu chlamydii, rzeżączki lub rzęsistkowicy2028
  • Ponowne badanie w trzecim trymestrze ciąży dla kobiet poniżej 25 roku życia lub z grupy ryzyka20

Optymalny interwał między badaniami przesiewowymi w kierunku STI jest niepewny. W przypadku osób z wcześniejszymi negatywnymi wynikami badań przesiewowych, interwał ponownej oceny będzie zależał od utrzymywania się lub zmiany profilu czynników ryzyka. Pozytywne wyniki badań przesiewowych są markerem ryzyka i uzasadniają częstsze badania29.

Nowoczesne technologie w diagnostyce STD

Rozwój nowoczesnych technologii diagnostycznych znacząco poprawił skuteczność wykrywania chorób przenoszonych drogą płciową. Te innowacje umożliwiają szybszą, dokładniejszą i bardziej dostępną diagnostykę30.

Testy Point-of-Care (POC)

Testy typu Point-of-Care (POC) to badania, które mogą być wykonywane przy łóżku pacjenta w szpitalu, w domu pacjenta, w gabinecie lekarskim lub w terenie19.

Zalety testów POC obejmują:

  • Szybkie wyniki – często dostępne w ciągu kilkunastu minut
  • Łatwość użycia – nie wymagają specjalistycznego sprzętu laboratoryjnego
  • Możliwość wykonania poza tradycyjnym laboratorium31

Światowa Organizacja Zdrowia (WHO) uważa rozwój i wdrożenie testów POC dla zarządzania STI za priorytet i opracowała profile docelowych produktów (TPP) dla testów POC19.

Szybkie, proste w użyciu, finansowo dostępne i o zapewnionej jakości testy POC są pilnie potrzebne, aby umożliwić badania przesiewowe, diagnozę i, gdy to możliwe, leczenie przy pierwszym kontakcie z pacjentami22.

Testy domowe i samodzielne pobieranie próbek

Testy domowe i zestawy do samodzielnego pobierania próbek zyskują coraz większą popularność, szczególnie w przypadku takich chorób jak HIV, chlamydia i rzeżączka27.

Zalety tych testów obejmują:

  • Większą prywatność i wygodę dla pacjentów12
  • Zwiększoną dostępność badań, szczególnie dla osób, które mogą mieć trudności z dostępem do tradycyjnej opieki zdrowotnej3
  • Zmniejszenie barier związanych ze stygmatyzacją27

Jednakże, należy pamiętać, że testy wykonane na próbkach pobranych samodzielnie mogą nie zawsze być dokładne, a wyniki fałszywie negatywne są dość częste1227.

Według CDC, postępując zgodnie z instrukcjami pobierania krok po kroku, pacjenci mogą prawidłowo pobrać własne próbki, a wyniki testów są tak samo dokładne, jak gdy są pobierane przez lekarza32.

Panele diagnostyczne STD

Panele diagnostyczne STD to kompleksowe zestawy testów, które badają obecność wielu różnych chorób przenoszonych drogą płciową jednocześnie33.

Zalety paneli diagnostycznych obejmują:

  • Możliwość jednoczesnego wykrycia wielu różnych patogenów17
  • Oszczędność czasu i kosztów w porównaniu z wykonywaniem pojedynczych testów33
  • Zwiększoną szansę wykrycia współistniejących zakażeń17

Przykładowe panele diagnostyczne obejmują badania w kierunku:

  • Podstawowy panel STD – chlamydia, rzeżączka, kiła i HIV32
  • Rozszerzony panel STD – chlamydia, rzeżączka, wirusowe zapalenie wątroby typu B i C, rzęsistkowica, kiła, HIV-1 i HIV-233
  • Kompleksowy panel STD – uwzględniający dodatkowo mykoplazmy i ureaplazmy34

Warto zauważyć, że niektóre laboratoria oferują panele STD, które pozwalają wykryć ponad 30 różnych bakterii, wirusów i pasożytów35.

Wyzwania i bariery w diagnostyce STD

Mimo postępu w dziedzinie diagnostyki chorób przenoszonych drogą płciową, istnieje wiele wyzwań i barier, które utrudniają efektywne wykrywanie i leczenie tych infekcji31.

Problemy związane z dostępem do badań

Dostęp do badań w kierunku chorób przenoszonych drogą płciową może być ograniczony z różnych powodów:

  • Brak świadomości lub wiedzy na temat dostępnych testów31
  • Ograniczenia finansowe – wysokie koszty niektórych testów19
  • Ograniczenia geograficzne – utrudniony dostęp do placówek medycznych, szczególnie na obszarach wiejskich lub oddalonych19
  • Stygmatyzacja i obawy przed osądzeniem ze strony personelu medycznego27

Dokładne testy diagnostyczne dla STI (wykorzystujące technologię molekularną) są szeroko stosowane w krajach o wysokich dochodach. Są one szczególnie przydatne do diagnozowania bezobjawowych infekcji. Jednak są one w dużej mierze niedostępne w krajach o niskich i średnich dochodach (LMIC) w przypadku chlamydii i rzeżączki. Nawet w krajach, gdzie testy są dostępne, są one często drogie i nie są szeroko dostępne. Ponadto, czas potrzebny na otrzymanie wyników jest często długi. W rezultacie, może to utrudniać obserwację i opieka lub leczenie mogą być niekompletne24.

Wyzwania w diagnostyce bezobjawowych infekcji

Jednym z największych wyzwań w diagnostyce chorób przenoszonych drogą płciową jest fakt, że wiele z tych infekcji przebiega bezobjawowo lub z objawami nieswoistymi24.

Problemy związane z diagnozowaniem bezobjawowych infekcji obejmują:

  • Niską motywację do badań u osób bez objawów21
  • Trudności w identyfikacji osób, które powinny być badane5
  • Koszty związane z badaniami przesiewowymi dużych populacji29

STI są często bezobjawowe. Gdy objawy występują, mogą być nieswoiste24. Do 90% zakażeń przenoszonych drogą płciową jest bezobjawowych23. W wielu przypadkach osoby nigdy nie zgłaszają doświadczania oznak lub objawów posiadania STI21.

Jedynym sposobem, aby dowiedzieć się na pewno, czy masz STI, jest wykonanie testu21.

Jakości i wiarygodność testów

Jakość i wiarygodność testów diagnostycznych w kierunku chorób przenoszonych drogą płciową może się znacznie różnić w zależności od rodzaju testu, producenta i warunków wykonania36.

Problemy związane z jakością i wiarygodnością testów obejmują:

  • Możliwość wyników fałszywie dodatnich i fałszywie ujemnych36
  • Zmienną czułość i swoistość różnych testów19
  • Wpływ warunków przechowywania i transportu próbek na wyniki17

Jakość i stężenie wyekstrahowanego DNA ma kluczowe znaczenie dla prawidłowego działania zestawu diagnostycznego17.

Testy w kierunku chorób przenoszonych drogą płciową mogą być bardzo dokładne, gdy są odpowiednio stosowane i interpretowane wraz z innymi informacjami klinicznymi. Jednakże, istotne jest, aby wziąć pod uwagę ograniczenia badania STI, w tym możliwość wyników fałszywie ujemnych i fałszywie dodatnich36.

Znaczenie diagnostyki STD w zdrowiu publicznym

Diagnostyka chorób przenoszonych drogą płciową odgrywa kluczową rolę w zdrowiu publicznym, przyczyniając się do kontroli i zapobiegania tym infekcjom na poziomie populacyjnym37.

Rola diagnostyki w kontroli i zapobieganiu STD

Diagnostyka chorób przenoszonych drogą płciową jest niezbędna do skutecznej kontroli i zapobiegania tym infekcjom z kilku powodów:

  • Umożliwia wczesne wykrycie i leczenie zakażeń, co zmniejsza ryzyko powikłań i dalszego rozprzestrzeniania się choroby37
  • Pozwala na identyfikację i leczenie partnerów seksualnych osób zakażonych5
  • Dostarcza danych epidemiologicznych niezbędnych do monitorowania trendów i planowania interwencji zdrowia publicznego38

Podstawowym celem zdrowia publicznego i opieki zdrowotnej jest zapobieganie zakażeniom i leczenie ich, zanim rozwiną się w chorobę37.

Odpowiednie praktyki testowania w kierunku STD mają kluczowe znaczenie dla wysiłków mających na celu kontrolę i zapobieganie tym chorobom. Wzorce testowania mogą również wpływać na naszą zdolność do monitorowania trendów w częstości występowania STD38.

Nadzór epidemiologiczny i zgłaenia przypadków

Nadzór epidemiologiczny i zgłaszanie przypadków chorób przenoszonych drogą płciową są kluczowymi elementami strategii zdrowia publicznego39.

System nadzoru epidemiologicznego obejmuje:

  • Obowiązkowe zgłaszanie określonych chorób przenoszonych drogą płciową przez świadczeniodawców i laboratoria39
  • Monitorowanie trendów w częstości występowania i zapadalności na STD22
  • Identyfikację ognisk epidemicznych i szybkie reagowanie39

W wielu krajach prywatne i publiczne szpitale, laboratoria, lekarze i inni świadczeniodawcy są zobowiązani przez prawo do zgłaszania pozytywnych wyników STD, takich jak chlamydia, rzeżączka i kiła, do odpowiednich organów zdrowia publicznego w ciągu 24 godzin od uzyskania pozytywnych wyników39.

Nadzór jest odpowiedzialny za weryfikację diagnozy i leczenia wszystkich STD podlegających obowiązkowi zgłaszania od publicznych i prywatnych świadczeniodawców39.

Współpraca między sektorami opieki zdrowotnej

Skuteczna diagnostyka i kontrola chorób przenoszonych drogą płciową wymaga współpracy między różnymi sektorami opieki zdrowotnej40.

Ważne obszary współpracy obejmują:

  • Współpracę między świadczeniodawcami podstawowej opieki zdrowotnej a specjalistami w dziedzinie chorób zakaźnych41
  • Partnerstwo między publicznymi a prywatnymi placówkami opieki zdrowotnej30
  • Współpracę między laboratoriami a klinicystami38

Lokalne i stanowe praktyki zdrowia publicznego dotyczące powiadamiania partnerów i zgłaszania chorób są ważne, oprócz indywidualnego zarządzania przypadkami chorób przenoszonych drogą płciową5.

Kontrola STI zależy od edukacji pracowników opieki zdrowotnej i społeczeństwa, unikania zachowań wysokiego ryzyka przez pacjentów, odpowiedniego dostępu do placówek i wyszkolonego personelu do diagnostyki i leczenia, programów zdrowia publicznego mających na celu lokalizowanie i leczenie ostatnich partnerów seksualnych pacjentów oraz obserwacji leczonych pacjentów w celu upewnienia się, że zostali wyleczeni40.

Perspektywy przyszłości w diagnostyce STD

Diagnostyka chorób przenoszonych drogą płciową stale się rozwija, a nowe technologie i podejścia obiecują poprawę skuteczności wykrywania i leczenia tych infekcji30.

Nowe technologie i metody diagnostyczne

Rozwój nowych technologii diagnostycznych oferuje obiecujące perspektywy dla przyszłości diagnostyki STD:

  • Zaawansowane testy molekularne o zwiększonej czułości i swoistości19
  • Platformy diagnostyczne umożliwiające jednoczesne wykrywanie wielu patogenów17
  • Innowacyjne testy typu POC o zwiększonej dokładności i dostępności22

Innym głównym przesunięciem jest przejście w kierunku większej ilości diagnostyki molekularnej dla diagnozowania STD30.

Postępy w technologii, w połączeniu ze zwiększoną świadomością i innowacyjnymi podejściami do testowania, mają kluczowe znaczenie w kształtowaniu przyszłości, w której wczesne wykrycie i interwencja mogą skutecznie łagodzić wpływ STD30.

Badania nad nowymi metodami wykrywania STD

Trwają intensywne badania nad nowymi metodami wykrywania chorób przenoszonych drogą płciową:

  • Rozwijane są szybkie testy diagnostyczne dla kiły, chlamydii, rzeżączki i rzęsistkowicy22
  • Badania nad testami wykrywającymi oporność na antybiotyki u patogenów powodujących STD19
  • Podejścia omiczne (genomika, proteomika itp.) w diagnostyce STD19

Kilka innych szybkich testów jest w fazie rozwoju i ma potencjał do poprawy diagnostyki i leczenia STD, szczególnie w warunkach ograniczonych zasobów24.

Szeroko rozpowszechnione i rutynowe wykorzystanie technologii -omicznych w kontekście klinicznym pozostaje do zobaczenia, szczególnie w laboratoriach o ograniczonych zasobach ekonomicznych i technicznych, ale przyszłość mimo to wydaje się obiecująca19.

Integracja z systemami e-zdrowia

Integracja diagnostyki STD z systemami e-zdrowia oferuje nowe możliwości dla poprawy dostępu do badań i zarządzania wynikami:

  • Platformy cyfrowe umożliwiające zamawianie testów i otrzymywanie wyników online42
  • Aplikacje mobilne wspierające badania przesiewowe i informowanie o ryzyku43
  • Systemy elektronicznej dokumentacji medycznej ułatwiające wymianę informacji między świadczeniodawcami36

Firmy poszerzają swoje portfolio diagnostyczne STD poprzez dodawanie zestawów do testów multipleksowych, rozwiązań do testów domowych i platform zdrowia cyfrowego wspieranych przez AI43.

W Kolumbii Brytyjskiej dostępne są opcje online dla testów STI. Więcej informacji można znaleźć w GetChecked Online, aby sprawdzić, czy jest to dostępne w Twojej społeczności42.

Jeśli masz obawy dotyczące opóźnień w otrzymywaniu wyników testów lub potrzeby dodatkowych badań, powinieneś otwarcie komunikować się ze swoim lekarzem36.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Sexually transmitted diseases (STDs) – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/sexually-transmitted-diseases-stds/diagnosis-treatment/drc-20351246
    Diagnosis of an STD starts with your sexual history and current symptoms. If these suggest that you have an STD, your health care professional may do a physical or pelvic exam to look for signs of infection. Some signs of infection are a rash, warts or discharge. […] Lab tests can find the cause of STD symptoms. They can also find sexually transmitted infections without symptoms. […] Blood tests can confirm the diagnosis of HIV or later stages of syphilis. […] Some STDs can be confirmed with a urine sample. […] If you have open genital sores, your health care professional may test fluid and samples from the sores to diagnose the type of infection. […] Testing for an STD or sexually transmitted infection in someone who doesn’t have symptoms is called screening. Most of the time, STI screening is not a routine part of health care.
  • #1 Sexually transmitted diseases (STDs) – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/sexually-transmitted-diseases-stds/diagnosis-treatment/drc-20351246
    But when a person’s risk for getting an STD changes, a health care professional may suggest screening. […] Experts recommend STI screening for: Almost everyone at least once. Guidelines suggest screening with a blood or saliva test for human immunodeficiency virus (HIV), the virus that causes AIDS, for everyone ages 15 to 65. […] Guidelines also recommend hepatitis C screening for all adults. […] All pregnant women will generally be screened for HIV, hepatitis B, chlamydia and syphilis early in the pregnancy. […] Experts recommend that all sexually active women under age 25 be tested for chlamydia infection. […] If you’ve been treated for a chlamydia infection, you should be retested in about three months. […] Having HIV raises your risk of getting other sexually transmitted diseases. Experts recommend testing for syphilis, gonorrhea, chlamydia and herpes right away after being diagnosed with HIV. […] If you think you might have a sexually transmitted infection, it’s best to avoid any sexual activity until you’ve talked with your doctor. […] If you do take part in sexual activity before seeing your doctor, be sure to follow safe sex practices, such as using a condom.
  • #2 Sexually Transmitted Infection (STI) Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/sexually-transmitted-infection-sti-tests/
    STIs (sexually transmitted infections) or sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. STIs are usually spread during vaginal, oral, or anal sex. But sometimes, they can spread through other sexual contact involving the penis, vagina, mouth, or anus. This is because some STIs, like herpes and HPV (human papillomavirus), are spread by skin-to-skin contact. […] Left untreated, certain STIs can cause long-term health problems such as blindness, brain damage, infertility, birth defects, and even death. Fortunately, all STIs can be treated, and some can be cured. However, that doesn’t prevent you from getting infected again if you don’t take steps to prevent infection. STI testing can help you get diagnosed and treated so you may avoid serious complications.
  • #3 STD/STI Testing: What To Expect
    https://my.clevelandclinic.org/health/diagnostics/std-testing
    STI testing (STD testing) refers to many different tests you get at a healthcare providers office or clinic to find out if you have a sexually transmitted infection. […] STI testing (STD testing) tells you if you have a sexually transmitted infection (STI). STIs, formerly called sexually transmitted diseases (STDs), are contagious conditions that spread through sexual activity. […] Knowing you have an STI is important because you can then: Get treatment as soon as possible. Timely treatment improves your chances of recovering and avoiding long-term issues. STIs can lead to serious complications like vision loss, organ damage and infertility. In some cases, STIs can be deadly. […] Based on this open and honest conversation, your provider will advise you on STI testing. In some cases, they may recommend you get STI screenings.
  • #3 STD/STI Testing: What To Expect
    https://my.clevelandclinic.org/health/diagnostics/std-testing
    You can buy at-home STI testing kits through local health clinics and pharmacies. […] Your healthcare provider can test for STIs in their office. But if you don’t have a usual provider or aren’t comfortable talking to your provider about STI testing, other options are available. […] Take the time to learn more about STI testing and how it can help you stay healthy.
  • #4 Sexually Transmitted Infections (STIs): Sexually Transmitted Diseases (STDs)
    https://my.clevelandclinic.org/health/diseases/9138-sexually-transmitted-diseases–infections-stds–stis
    Sexually transmitted infections (STI) are infections or conditions that you can get from any kind of sexual activity involving your mouth, anus, vagina or penis. Another common name for STIs is sexually transmitted diseases, or STDs. […] The Centers for Disease Control and Prevention (CDC) recommends regular STI screenings or testing if you’re sexually active. […] A healthcare provider will diagnose a sexually transmitted infection (sexually transmitted disease) after a physical exam and testing. […] A sexually transmitted infection test is a medical test to determine if you have an STI. […] Most healthcare providers recommend annual sexually transmitted infection testing. […] The goal of sexually transmitted infection (sexually transmitted disease) treatment is to cure many (not all) STIs. […] Many sexually transmitted infections (sexually transmitted diseases) can be cured. Unfortunately, there isn’t a cure for all STIs. Conditions like HIV require lifelong care and treatment.
  • #5 Screening for sexually transmitted infections – UpToDate
    https://www.uptodate.com/contents/screening-for-sexually-transmitted-infections
    Screening for sexually transmitted infections (STIs) is a major public health problem in both resource-rich and limited settings. The immediate goal of screening for STIs is to identify and treat infected persons before they develop complications and to identify, test, and treat their sex partners to prevent transmission and reinfections. […] The approach to STI diagnosis and management is based upon disease or symptom-specific syndromes, including vaginal discharge, urethral discharge, ulcerative genital disease, nonulcerative genital disease, and pelvic pain. However, many patients have asymptomatic disease, which increases the risk of complications and sustained transmission in the community. Thus, screening is an important approach to identify and treat infected individuals, who would otherwise go undetected.
  • #5 Screening for sexually transmitted infections – UpToDate
    https://www.uptodate.com/contents/screening-for-sexually-transmitted-infections
    Individuals who are seeking an STI evaluation often do so because of a specific exposure. In such cases, we screen for the following infections: Gonorrhea, Chlamydia, Syphilis, HIV, and Trichomoniasis. […] Testing for sexually transmitted infections generally involves a blood test and/or self-collection of relevant body fluid specimens. […] Management of sexually transmitted infections depends on the specific infection. Diagnosis of non-viral STIs generally should result in prompt treatment, since a few individuals may develop complications in the interval between screening and treatment. […] Local and state public health practices of partner notification and disease reporting are important, in addition to individual sexually transmitted disease case management. […] For gonorrhea, chlamydia, syphilis, and Trichomonas, sex partners should be notified, examined, and treated for the STI identified or suspected in the index patient.
  • #6 Sexually Transmitted Infections (STIs)
    https://www.unitypoint.org/find-a-service/primary-care/sexually-transmitted-infections
    We provide comprehensive, confidential and judgement-free testing and treatment for sexually transmitted infections (STIs), often referred to as sexually transmitted diseases (STDs). […] If you think you have an STD, its important to get tested. The sooner you treat an STD, the quicker you stop any spread, feel better and reduce your risk of serious disease. […] If you have been sexually active and potentially exposed to an STD and/or you have signs and symptoms of an STD, get tested as soon as possible. UnityPoint Health tests and treats the following STDs, including, but not limited to: […] A provider will ask you about your symptoms and your medical and sexual history. Answering questions honestly will help our team get you the right care. In addition, the provider will do a physical exam and testing.
  • #7 Sexually Transmitted Diseases (STDs): Diagnosis & Treatment | NewYork-Presbyterian
    https://www.nyp.org/primary-care/sexually-transmitted-diseases-stds/treatment
    How are STDs Diagnosed? Diagnosis If you or your doctor suspect you have an STD, your provider will perform physical and pelvic exams to assess your symptoms. They will look for signs of an infection, including sores, warts, unusual discharge, or a rash. Following this exam, your doctor may order additional tests to confirm a diagnosis, which may include: Blood tests. HIV and the late stages of syphilis can be diagnosed through a blood test. Fluid samples. Sores caused by genital herpes can produce fluids that, when tested, can confirm the presence of the herpes virus. Urine samples. Some STDs, including gonorrhea and chlamydia, can be identified in a urine sample. Regular screenings for STDs can help diagnose any new infection early and give you the best chance for a good prognosis. Everyone who is sexually active should undergo regular screening for STDs, but screenings are highly recommended for the following groups: those with multiple partners, men who have sex with men, pregnant women, people who are HIV positive, and people who have a new sexual partner.
  • #8 Sexually Transmitted Diseases: Types, Symptoms, Treatment
    https://www.healthline.com/health/sexually-transmitted-diseases
    Sexually transmitted infections can lead to sexually transmitted diseases. Treatment can depend on your diagnosis. […] All STDs are caused by an STI. […] It’s hard for healthcare professionals to diagnose an STD based on symptoms alone, so they’ll need to do some tests and examinations. […] Depending on the suspected STD, this may involve: physical examinations, swabs of bodily fluids, blood tests, specialist procedures, such as keyhole surgery or a colposcopy. […] There are a number of treatment options, depending on the condition, including: antibiotics, other oral or topical medications, surgery, laser. […] Remember that, with most STDs, it’s not possible to undo any damage that the disease has already caused. And some STDs, such as genital warts and AIDS, aren’t curable. […] Many STDs are treatable, but not all of them are curable. Some can be life threatening, while others have less serious effects. They are, however, all caused by an STI. So the best way to prevent them is to get regularly screened and practice safer sex.
  • #9 Sexually Transmitted Diseases (STDs) Antibodies & Antigens | Meridian Bioscience
    https://www.meridianbioscience.com/lifescience/products/antibodies-antigens/sexually-transmitted-diseases/
    STDs are illnesses that are spread by sexual contact and are an important global health priority because of their devastating impact on women and infants. […] Early and rapid diagnosis of an STD increases the chance to limit effects of the disease. […] There are five main methods for the diagnosis of STDs which include: 1) culture; 2) microscopy; 3) detection of antigens or enzymes; 4) detection of nucleic acid sequences (NAAT); 5) detection of antibodies. Of the five approaches, the assays that provide the most rapid diagnosis, specifically the detection of antibodies by rapid serologic methods, and specific detection of cellular components, including antigens, enzymes, or nucleic acid sequences (especially with amplification), have gained the most acceptance.
  • #10 How do health care providers diagnose a sexually transmitted disease (STD) or sexually transmitted infection (STI)? | NICHD – Eunice Kennedy Shriver National Institute of Child Health and Human Development
    http://www.nichd.nih.gov/health/topics/stds/conditioninfo/diagnosed
    Any person who is sexually active should discuss his or her risk factors for STDs/STIs with a health care provider and ask about getting tested. […] You should get tested and have regular checkups with a health care provider who can help assess and manage your risk, answer your questions, and diagnose and treat an STD/STI if needed. […] Some STDs/STIs may be diagnosed during a physical exam or through microscopic examination of a sore or fluid swabbed from the vagina, penis, or anus. […] Blood tests are used to detect infections such as hepatitis A, B, and C or HIV/AIDS. […] If you receive a notice, it is important to see a health care provider, be tested, and start treatment right away. […] During an early prenatal visit, with the help of her health care provider, an expectant mother should be screened for these infections, including HIV and syphilis.
  • #11 Diagnosis of sexually transmitted diseases • OT.CO Clinic
    https://otcoclinic.com/blog/diagnostic-disease-transmitted-pathways/
    The most common symptom of candidiasis is itching, burning of the vagina or vulva, irritation and redness of the mucosa, pain on urination. […] Proper treatment of a given sexually transmitted disease and prevention of serious consequences is only possible with the right diagnosis. […] Tests to detect the presence of a specific bacteria are most commonly performed. […] Regular screening is essential, especially if you have multiple partners or are pregnant.
  • #12 STD testing: What’s right for you?
    https://www.mayoclinic.org/diseases-conditions/sexually-transmitted-diseases-stds/in-depth/std-testing/art-20046019
    National guidelines recommend hepatitis B screening for people age 18 and older at least once, and with a test that includes a few different markers of the virus. […] If you have any of the following risk factors, talk to your health care provider about testing for HIV, syphilis or hepatitis: Symptoms of infection, Positive test for another STI, which puts you at greater risk of other STIs. […] Your health care provider tests you for syphilis by taking either a blood sample or a swab from any genital sores you might have. […] Providers generally only recommend testing for genital herpes for people who have symptoms or other risk factors. […] A blood test also may tell if you had a past herpes virus infection, but results aren’t always reliable. […] Regular HPV testing isn’t recommended for men.
  • #12 STD testing: What’s right for you?
    https://www.mayoclinic.org/diseases-conditions/sexually-transmitted-diseases-stds/in-depth/std-testing/art-20046019
    Sexually transmitted diseases are common, but the types of STD testing you need may vary by your risk factors. Find out what’s recommended for you. […] Getting tested is important. That’s because you can have a STD without knowing it. In many cases, there aren’t any symptoms. […] But what types of STI testing do you need? And how often should you be screened? The answers depend on your age, your sexual behaviors and other risk factors. […] Health care providers screen people for chlamydia and gonorrhea using a swab test or urine test. The sample is then studied in a lab. Screening is important, because if you don’t have symptoms, you may not know that you’re infected. […] The U.S. Preventive Services Taskforce encourages HIV testing, at least once, as a routine part of health care if you’re between the ages of 15 and 65.
  • #12 STD testing: What’s right for you?
    https://www.mayoclinic.org/diseases-conditions/sexually-transmitted-diseases-stds/in-depth/std-testing/art-20046019
    At-home test kits for certain STIs, such as HIV, chlamydia and gonorrhea, have become more common and popular. […] However, tests done on samples you collect yourself may not always be accurate. […] If you test positive for an STI, consider additional testing. Then get treatment from your health care provider if needed.
  • #13 Diagnostic Testing of Most Common Sexually Transmitted Infections
    https://www.myhealthtoolkit.com/web/public/brands/medicalpolicy/external-policies/diagnostic-testing-of-most-common-sexually-transmitted-infections/
    Diagnostic Testing of Most Common Sexually Transmitted Infections – CAM 209 […] Sexually transmitted infections (STIs), often referred to as sexually transmitted diseases or STDs, include a variety of pathogenic bacteria, virus, and other microorganisms that are spread through sexual contact and can cause a multitude of complications if left untreated. […] This policy is limited to testing for C. trachomatis, N. gonorrhoeae, T. pallidum, T. vaginalis, HSV, and HPV. […] Antibody testing for syphilis infection is considered MEDICALLY NECESSARY in the following situations: For any asymptomatic person in a high-risk category, once a year assessment using either a standard or reverse algorithm that includes initial and confirmatory tests for any initial positive test. […] Polymerase chain reaction (PCR) testing and nucleic acid amplification testing (NAAT) for syphilis is considered NOT MEDICALLY NECESSARY. […] NAAT for chlamydia is considered MEDICALLY NECESSARY in the following situations: Once a year assessment for any asymptomatic person in a high-risk category. […] NAAT for gonorrhea is considered MEDICALLY NECESSARY in the following situations: Once a year assessment for any asymptomatic person in a high-risk category. […] For symptomatic individuals, testing for Mycoplasma genitalium using NAAT is considered MEDICALLY NECESSARY. […] For individuals with active genital ulcers or mucocutaneous lesions, nucleic acid amplification testing (NAAT) for herpes simplex virus-1 (HSV-1) or herpes simplex virus-2 (HSV-2) is considered MEDICALLY NECESSARY. […] In the diagnosis and/or assessment of cancer or cancer therapy, testing for HR-HPV is considered MEDICALLY NECESSARY. […] Testing for HPV is considered NOT MEDICALLY NECESSARY in the following situations: To screen for oncogenic high-risk types, such as HPV-16 and HPV-18, as part of a general sexually transmitted disease (STD) or sexually transmitted infection (STI) screening process or panel for asymptomatic individuals. […] The standard protocol for diagnosing a syphilis infection is to use a two-tiered serological testing algorithm of treponemal testing and nontreponemal testing. […] NAAT has not been FDA-approved at this time and is not typically performed for genital syphilis. […] The CDC states that type-specific HSV-2 serologic assays for diagnosing HSV-2 are useful in the following scenarios: recurrent or atypical genital symptoms or lesions with a negative HSV PCR or culture result, clinical diagnosis of genital herpes without laboratory confirmation, and a patient’s partner has genital herpes. […] The CDC also recommends that, prior to donating, prospective hematopoietic stem cell transplant donors should be tested for syphilis. […]
  • #14 Diagnostic Testing of Most Common Sexually Transmitted Infections
    https://www.accrue-health.com/web/public/brands/medicalpolicy/external-policies/diagnostic-testing-of-most-common-sexually-transmitted-infections/
    Diagnostic Testing of Most Common Sexually Transmitted Infections – CAM 209 […] Sexually transmitted infections (STIs), often referred to as sexually transmitted diseases or STDs, include a variety of pathogenic bacteria, virus, and other microorganisms that are spread through sexual contact and can cause a multitude of complications if left untreated. […] This policy is limited to testing for C. trachomatis, N. gonorrhoeae, T. pallidum, T. vaginalis, HSV, and HPV. […] Antibody testing for syphilis infection is considered MEDICALLY NECESSARY in the following situations: For any asymptomatic person in a high-risk category, once a year assessment using either a standard or reverse algorithm that includes initial and confirmatory tests for any initial positive test. […] Polymerase chain reaction (PCR) testing and nucleic acid amplification testing (NAAT) for syphilis is considered NOT MEDICALLY NECESSARY. […] NAAT for chlamydia is considered MEDICALLY NECESSARY in the following situations: Once a year assessment for any asymptomatic person in a high-risk category. […] NAAT for gonorrhea is considered MEDICALLY NECESSARY in the following situations: Once a year assessment for any asymptomatic person in a high-risk category. […] For symptomatic individuals, testing for Mycoplasma genitalium using NAAT is considered MEDICALLY NECESSARY. […] For individuals with active genital ulcers or mucocutaneous lesions, nucleic acid amplification testing (NAAT) for herpes simplex virus-1 (HSV-1) or herpes simplex virus-2 (HSV-2) is considered MEDICALLY NECESSARY. […] In the diagnosis and/or assessment of cancer or cancer therapy, testing for HR-HPV is considered MEDICALLY NECESSARY. […] Testing for HPV is considered NOT MEDICALLY NECESSARY in the following situations: To screen for oncogenic high-risk types, such as HPV-16 and HPV-18, as part of a general sexually transmitted disease (STD) or sexually transmitted infection (STI) screening process or panel for asymptomatic individuals. […] The standard protocol for diagnosing a syphilis infection is to use a two-tiered serological testing algorithm of treponemal testing and nontreponemal testing. […] NAAT has not been FDA-approved at this time and is not typically performed for genital syphilis. […] The CDC states the signs and symptoms of neurosyphilis can include severe headache, trouble with muscle movements, muscle weakness or paralysis, numbness, and changes in mental status. […] The CDC also recommends that, prior to donating, prospective hematopoietic stem cell transplant donors should be tested for syphilis. […] The CDC recommends that men with recurrent nongonococcal urethritis (NGU) should be tested for M. genitalium using an FDA-cleared NAAT. […] The CDC recommends that screening of asymptomatic M. genitalium infection among women and men or extragenital testing for M. genitalium is not recommended. […]
  • #15 Sexually-Transmitted Infections (STIs) Increased Risk Panel | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/36963/sexually-transmitted-infections-stis-increased-risk-panel?p=r&cc=MASTER
    Sexually-Transmitted Infections (STIs) Increased Risk Panel – If someone is at an increased risk for STIs, they should be tested for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium. A panel will help the clinician identify and treat the appropriate pathogen if present. […] Includes Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital Trichomonas vaginalis RNA, Qualitative, TMAMycoplasma genitalium, rRNA, TMA […] Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen. […] Methodology Transcription-Mediated Amplification (TMA) […] Reference Range(s) Not detected […] Alternative Name(s) Trichomoniasis, Vaginitis, CT/GC APTIMA®, Urine Trichomonas, CT/NG APTIMA®, CT/NG TMA, STI Increased Risk Panel, STD Panel, Hologic, Mycoplasma genitalium TMA […] Preferred Specimen(s) Female Vaginal or endocervical swab collected in an Aptima® transport tube or 2 mL urine collected in an Aptima transport tube Male Urethral swab collected in an Aptima transport tube or 2 mL urine collected in an Aptima transport tube.
  • #16 Sexually transmitted infection – Wikipedia
    https://en.wikipedia.org/wiki/Sexually_transmitted_infection
    A sexually transmitted infection (STI), also referred to as a sexually transmitted disease (STD), is an infection that is spread by sexual activity, especially vaginal intercourse, anal sex, oral sex, or sometimes manual sex. STIs often do not initially cause symptoms, which results in a risk of transmitting them on to others. Symptoms and signs of STIs may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain. Some STIs can cause infertility. […] STI diagnostic tests are usually easily available in the developed world, but they are often unavailable in the developing world. […] Testing may be for a single infection, or consist of a number of tests for a range of STIs, including tests for syphilis, trichomonas, gonorrhea, chlamydia, herpes, hepatitis, and HIV. No procedure tests for all infectious agents.
  • #17 Sexually transmitted diseases molecular diagnostic test
    https://operondx.com/molecular-diagnostics/std-panel/
    Test for the detection of 10 pathogens associated to sexual transmitted diseases. The STD Panel Strip test is a test based on the reverse blot technique that allows the detection of 10 pathogens associated to sexually transmitted diseases. […] At present, sexually transmitted diseases (STDs) make up the most common group of infectious diseases that must be reported in the majority of the world’s countries. Their incidence is elevated, exceeding one million infections per day. In fact, this current trend of permanent increase, especially among young people under 25 years, makes the early and accurate diagnosis of the disease of great interest. […] The majority of STDs have treatments and are curable. However, an untreated STD can lead to serious long-term health problems. […] The STD Panel Strip test allows the detection of 10 pathogens associated to sexual transmitted diseases: Chlamydia trachomatis (discriminating variants L1, L2 and L3, that cause lymphogranuloma venereum), Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Herpes simplex 1, Herpes simplex 2, and Treponema pallidum.
  • #17 Sexually transmitted diseases molecular diagnostic test
    https://operondx.com/molecular-diagnostics/std-panel/
    Detection of co-infections. […] 10 pathogens in one test. […] Differentiates between HSV1 and HSV2. […] Differentiation of LGV causative variants. […] Detection of 10 of the most common pathogens that cause sexually transmitted diseases in a single strip. Each pathogen is detected in a different line, which makes this test the ideal tool for detecting co-infections. […] Differentiation between Herpes simplex 1 (HSV1) and Herpes simplex 2 (HSV2), in separate bands. […] Differentiation between L1, L2 and L3 variants of Chlamydia. […] Several types of validated samples. […] How long does it take to detect sexually transmitted diseases?: How long it takes for an STD to show up in testing is entirely dependent on the STD itself, how long its own incubation period is, and the body’s immune response. […] The test has been designed and validated for use with DNA obtained from smears of various origins (urethral, endocervical, rectal, vaginal), and from urine. […] The quality and concentration of the DNA extracted is of vital importance for the proper performance of the kit.
  • #18 Azthena logo with the word Azthena
    https://www.news-medical.net/health/STD-Diagnosis.aspx
    Discharge from genital sores, ulcers or from the vagina and penis are examined under the microscope for the presence of microbes. […] The Pap test is performed to screen all women for the abnormal structure of cervical cells. These can arise as a result of infection with certain strains of the human papillomavirus (HPV). Starting from the age of 21, all women should receive a Pap smear every three years.
  • #19 Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections
    https://www.mdpi.com/1660-4601/18/3/1038
    Currently available laboratory diagnostic approaches for the detection of active STIs are summarized in Table 1 and discussed in more detail below. […] The use of the most sensitive and specific tests is often impractical in resource-poor or remote areas due to their high cost and technical requirements. In addition, considering the clinical presentation and the severe complications associated with some STIs if left untreated, the “ideal” diagnostic test should be quick so that the patient is treated on the spot. […] NAATs have a significantly lower turnaround time (they can be easily automated, and the time to result is significantly lower than that of traditional approaches), they allow the detection of organisms which cannot be grown in culture, and they have a significantly higher sensitivity (a dramatically relevant advantage for asymptomatic infections where the organisms’ load is low).
  • #19 Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections
    https://www.mdpi.com/1660-4601/18/3/1038
    The clinical presentation per se does not always allow a specific STI to be identified. In these cases, etiological diagnosis via laboratory confirmation of the underlying organisms is essential. Other than supporting a more rational use of antimicrobials, laboratory confirmation is pivotal in surveillance (to determine the true scale of the spread of STIs in communities) and in screening (i.e., testing of at-risk people without recognized signs or symptoms). […] Point-of-care (POC) tests represent an answer to the problem of needing to reach a diagnosis quickly outside of a standard laboratory. By definition, a POC test can be performed at the patient’s hospital bedside or own house, the physician’s office, or in the field. […] The development and implementation of POCs for STI management is considered a priority by WHO, and target product profiles (TPPs) for POCs have been developed.
  • #19 Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections
    https://www.mdpi.com/1660-4601/18/3/1038
    In addition to the detection of the organism per se, it is important to identify the presence of potential antimicrobial resistance (AMR). This information is pivotal, not only to guide the most appropriate pharmacological treatment course for the patient, but also to prevent the further selection and spread of resistance determinants. […] The widespread and routine use of -omics technologies in a clinical context remains to be seen, particularly in laboratories with limited economic and technical resources, but the future nevertheless appears promising.
  • #20 STI Screening Recommendations
    https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
    Sexually active women under 25 years of age1 […] Sexually active women 25 years of age and older if at increased risk*1 […] Retest approximately 3 months after treatment2 […] Rectal chlamydial testing can be considered in females based on reported sexual behaviors and exposure, through shared clinical decision between the patient and the provider2,3,4 […] All pregnant women under 25 years of age1 […] Pregnant women 25 years of age and older if at increased risk*1 […] Retest during the 3rd trimester for women under 25 years of age or at risk2 […] Pregnant women with chlamydial infection should have a test of cure 4 weeks after treatment and be retested within 3 months2 […] There is insufficient evidence for screening among heterosexual men who are at low risk for infection, however, screening young men can be considered in high prevalence clinical settings (adolescent clinics, correctional facilities, STI/sexual health clinic)1,5
  • #20 STI Screening Recommendations
    https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
    At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use2 […] Every 3 to 6 months if at increased risk (i.e., MSM on PrEP, with HIV infection, or if they or their sex partners have multiple partners)2 […] Screening recommendations should be adapted based on anatomy, (i.e., annual, routine screening for chlamydia in cisgender women 25 years old should be extended to all transgender men and gender diverse people with a cervix. If over 25 years old, persons with a cervix should be screened if at increased risk.)2 […] For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter2,6 […] More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology2 […] Type-specific HSV serologic testing can be considered for women presenting for an STI evaluation (especially for women with multiple sex partners)2
  • #20 STI Screening Recommendations
    https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
    Routine HSV-2 serologic screening among asymptomatic pregnant women is not recommended. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy2 […] Consider screening for women receiving care in high-prevalence settings (e.g., STI clinics and correctional facilities) and for asymptomatic women at high risk for infection (e.g., women with multiple sex partners, transactional sex, drug misuse, or a history of STI or incarceration)2 […] All women aged 13-64 years (opt-out)9,10 […] All women who seek evaluation and treatment for STIs2,10 […] All pregnant women should be screened at first prenatal visit (opt-out)9, 10 […] Retest in the 3rd trimester if at high risk (people who use drugs, have STIs during pregnancy, have multiple sex partners during pregnancy, have a new sex partner during pregnancy, live in areas with high HIV prevalence, or have partners with HIV)11
  • #20 STI Screening Recommendations
    https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
    Rapid testing should be performed at delivery if not previously screened during pregnancy10 […] At least annually for sexually active MSM if HIV status is unknown or negative and the patient or their sex partner(s) have had more than one sex partner since most recent HIV test2,10,12 […] Consider the benefits of offering more frequent HIV screening (e.g., every 36 months) to MSM at increased risk for acquiring HIV infection.2 […] For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter2, 18 […] More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology2 […] Type-specific HSV serologic testing should be considered for persons presenting for an STI evaluation (especially for those persons with multiple sex partners)2
  • #21 It’s Best to Test
    https://patient.questdiagnostics.com/BestToTest
    You might think you are too young or not at risk for an STI. […] But, almost 50% of new STIs were in people ages 15-24. […] And rememberin many cases, people never report experiencing signs or symptoms of having an STI. […] The only way to know for sure if you have an STI is to get tested. […] STI testing might be right for you if you fit into any one of the categories below: Women ages 15-25 should be screened for chlamydia and gonorrhea each year. […] Sexually active women ages 25 and older should be screened if they have higher risk factors for STIs, such as new or multiple sex partners, or a sex partner who has an STI. […] Pregnant women should be tested for chlamydia and gonorrhea early in pregnancy. […] The sooner you get tested, the sooner you can take action to protect your health and the health of your partner.
  • #22
    https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/stis/testing-diagnostics
    The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response. […] WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester. […] To drive innovation and disseminate information, key WHO activities can support uptake, scale-up, and access of STI testing and diagnostic technologies. […] Rapid, simple to use, financially accessible and quality-assured POC tests are urgently needed to enable screening, diagnosis and, when possible, treatment at the first contact with patients. […] Antimicrobial resistance in gonococci is a severe problem worldwide and, as culture is the only method allowing antimicrobial susceptibility testing, it is crucial to maintain and, where necessary, strengthen the culture capacity in all countries.
  • #22
    https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/stis/testing-diagnostics
    Global Sexually Transmitted Infections Programme The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of sexually transmitted infections as a public health threats. […] Appropriate sexually transmitted infections (STIs) diagnosis and treatment are crucial to prevent transmission, decrease deaths related to such infections (including still births and cervical cancer), while improving individual health, mens and womens sexual health, and the well-being of all people. […] The accurate identification of asymptomatic and symptomatic STIs depends on the availability of quality diagnostic tests and a validated screening strategy. […] In its normative and standard-setting work, WHO is an evidence-based organisation with a focus on public health. Ongoing reviews of studies and evidence in hepatitis, syphilis and HIV testing and diagnostics has resulted in recent guidelines.
  • #22
    https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/stis/testing-diagnostics
    Several laboratory tests and procedures for specific STIs are elaborated in the WHO „Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus”. […] The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis. […] This updated manual provides a basic understanding of the principles of laboratory and point-of-care (POC) testing in the context of screening and diagnosis. […] This document highlights the diagnostics available now to support scale-up and expanded access to screening to meet the growing testing demands in sexually transmitted infections. […] Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria.
  • #23 The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4746407/
    The treatment of sexual partners is important as well. […] The diagnostic and therapeutic algorithms can generally be tailored to the leading clinical manifestations (if the patient is symptomatic). […] If the availability of diagnostic tests is limited, effective treatment can also be initiated without any testing on the basis of the clinical findings alone, if these are clearly typical of a particular sexually transmitted disease. […] Patients with diagnosed urethritis should be tested for other sexually transmitted infections, including HIV and syphilis. […] The disease is transmitted exclusively by direct contact with the genito-anal or oral mucosa (less commonly, the skin) of infected persons, i.e., by sexual contact. […] The pathogen is generally revealed serologically by antibody detection in the framework of the diagnostic algorithm.
  • #23 The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4746407/
    All patients with syphilis should be tested for other sexually transmitted diseases, including gonorrhea and HIV. […] The risk of transmission depends on the concentration of the virus (HIV), the particular sexual practices involved, and any concomitant infection with other sexually transmitted diseases. […] The risk of HIV transmission can be lessened by: Rigorous treatment of sexually transmitted infections; Condoms; Antiretroviral therapy (ART); ART and condoms; Pre-exposure prophylaxis of HIV-negative sexual partners.
  • #23 The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4746407/
    The reported incidence of sexually transmitted infections (STIs) in Germany is rising. […] We discuss sexually transmitted infections presenting with genital, anal, perianal, or oral ulcers, urethritis, cervicitis, urethral or vaginal discharge, or genital warts. […] For most of these diseases, treatment of the patients sexual partner(s) is indicated. Diagnostic nucleic acid amplification techniques are over 90% sensitive and specific and are generally the best way to detect the responsible pathogen. […] Sexually transmitted infections are common around the world, and any such infection increases the patients risk of contracting other types of sexually transmitted infection. […] Up to 90% of sexually transmitted infections are asymptomatic. […] The treatment of sexually transmitted infections has the following objectives: To cure the infection in the individual patient as rapidly as possible, and to eliminate contagiousness as rapidly as possible in order to interrupt the chain of transmission; To prevent reinfection and recurrent infection.
  • #24
    https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
    STIs are often asymptomatic. When symptoms occur, they can be non-specific. […] Accurate diagnostic tests for STIs (using molecular technology) are widely used in high-income countries. These are especially useful for the diagnosis of asymptomatic infections. However, they are largely unavailable in low- and middle-income countries (LMICs) for chlamydia and gonorrhoea. Even in countries where testing is available, it is often expensive and not widely accessible. In addition, the time it takes for results to be received is often long. As a result, follow-up can be impeded and care or treatment can be incomplete. […] On the other hand, inexpensive, rapid tests are available for syphilis, hepatitis B and HIV. The rapid syphilis test and rapid dual HIV/syphilis tests are used in several resource-limited settings. […] Several other rapid tests are under development and have the potential to improve STI diagnosis and treatment, especially in resource-limited settings.
  • #25 Consensus document on the diagnosis and treatment of sexually transmitted diseases in adults, children and adolescents | Enfermedades Infecciosas y Microbiología Clínica
    https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-consensus-document-on-diagnosis-treatment-S0213005X17301908
    STD are the most common cause for infectious urethritis and cervicitis. […] Diagnosis will be made on the basis of symptoms and compatible physical examination, real-time PCR and/or culture of the different agents in urethral/cervical discharge. […] Proctitis is defined as an inflammation of the rectum, proctocolitis rectum/colon and enteritis inflammation of the small intestine. […] Diagnosis is made by PCR. […] The treatment of choice is doxycycline 100mg every 12hours for 21 days. […] Diagnosis is usually indirect, by serology (treponemal/non-treponemal). […] Patients with HIV infection should be treated with the same therapeutic regime as HIV-negative patients, penicillin being the treatment of choice. […] HPV infection is the most common STD in the world; up to three quarters of the world’s population will get infected by HPV at some point.
  • #26 What are the tests used to diagnose sexually transmitted diseases?
    https://www.icliniq.com/qa/hiv-testing/i-want-to-know-about-the-tests-to-check-for-sexually-transmitted-disease
    Chlamydia and gonorrhea screening is done either through a urine test or through a swab inside the penis in men or from the cervix in women. The sample is then analyzed in a laboratory. […] Pap test: Pap tests, which check the cervix for abnormal cells, are recommended every two years for women between ages 21 and 30. Women age 30 and older can wait three years between Pap tests if their past three tests have been normal. […] HPV test: Samples for the HPV test are collected from the cervical canal. This test usually is not offered to women younger than 30 because HPV infections that will ultimately clear up on their own are so common in this age group.
  • #27 Sexually Transmitted Diseases: Lab Tests to Diagnose STDs – MyHealth
    https://redcliffelabs.com/myhealth/lifestyle/sexually-transmitted-diseases-lab-tests-to-diagnose-stds/
    The World Health Organization reports that more than 1 million people acquire sexually transmitted diseases (STD). This shows that these types of infections are a lot more common than we anticipate. […] Several STDs often go undiagnosed due to no or minor symptoms. Only when the symptoms start getting worse is when people seek medical interventions. Lack of timely testing is also due to the ongoing stigma and lack of open conversations surrounding the conditions. […] Getting tested for STDs is crucial for quicker treatments before it turns for the worse. […] A regular STD screening rules out these complications, especially if you have a suspicion that you might have contracted the infection from someone. […] You might need an STD testing if: You are sexually active and have multiple sexual partners; You are a woman above the age of 21 and need to keep a check on your cervical health; You are pregnant and have an active sexually transmitted infection in your body; You had unprotected sex; You are a homosexual man, engaging in penetrative sex; You have been diagnosed with HIV; You have accidentally shared needles with an unknown person.
  • #27 Sexually Transmitted Diseases: Lab Tests to Diagnose STDs – MyHealth
    https://redcliffelabs.com/myhealth/lifestyle/sexually-transmitted-diseases-lab-tests-to-diagnose-stds/
    Besides these instances; you should also consider getting an STD testing done if you are experiencing symptoms like painful urination, pain during sexual intercourse, vaginal discharge or bleeding, etc. […] Most lab tests for STDs check for one of the following conditions: Chlamydia, Gonorrhea, HIV, Hepatitis B, Syphilis, Trichomoniasis. […] Most blood and urine tests check for bacterial or viral infections, including HIV, gonorrhea, chlamydia, and syphilis. […] Despite the convenience, blood and urine tests for STDs arent always the most accurate. Most STDs dont show up in the screening right after a person contracts it. […] It might take the infection up to a month after exposure to show up in the bloodstream or the urine. This is especially accurate for HIV, which has a window period of a few weeks to a few months before a test can detect its presence.
  • #27 Sexually Transmitted Diseases: Lab Tests to Diagnose STDs – MyHealth
    https://redcliffelabs.com/myhealth/lifestyle/sexually-transmitted-diseases-lab-tests-to-diagnose-stds/
    A general pap smear test can ascertain if the patient has an STD or not. For more accurate detection of the type of infection, a separate HPV test is prescribed. […] In patients with open genital sores, the doctors might prescribe fluid sample testing to ascertain what kind of STD the patient has. […] Lastly, in patients with prominent symptoms, a series of physical examinations can support the diagnosis. […] There are 20+ types of sexually transmitted diseases known to men. However, there are a handful of common STDs that lab tests prioritize. […] The self-testing kits for HIV, chlamydia, and gonorrhea are gaining more and more popularity. […] Remember that the self-testing kits arent 100% accurate. They can give false negatives quite often. So, if you have a suspicion that you might have come in contact with an STD infection, getting lab tests is a better option. […] STDs have various lab testing requirements that your doctor will discuss with you in detail. Depending on the reports, you will need treatments to overcome any lingering complications.
  • #28 Sexually Transmitted Infections (STIs): Diagnosis, Treatment and Prevention | Nationwide Children’s Hospital
    https://www.nationwidechildrens.org/conditions/sexually-transmitted-infections
    Most STIs can be treated. Many STIs can be cured, but some do not have a known cure. These may still be managed with medicines. […] There is not one test that looks for all STIs, so you may need 2 or more different tests. […] STIs can be tested through urine, blood, or genital discharge and open sores. Usually you can collect the specimen yourself, in private. […] Test results usually come back within 2 to 3 days or sooner. […] After treatment for chlamydia, gonorrhea, or trichomonas, you should be retested in three months to be sure you did not get that STI again, or any other STI. […] Some STIs make it easier for HIV to enter the skin and mucous membranes. If you have an STI, you should get tested for HIV.
  • #29 Screening for sexually transmitted infections – UpToDate
    https://www.uptodate.com/contents/screening-for-sexually-transmitted-infections/print
    There is little direct evidence supporting the efficacy of screening programs. Screening for chlamydia has been the most extensively studied. […] The major rationale for chlamydia and gonorrhea screening among males is to reduce infection or reinfection of existing partners and transmission to new partners. […] The incidence of syphilis has been increasing dramatically. In the United States, rates of primary and secondary syphilis have increased more than 150 percent among males and more than 850 percent among females since 2012; the rate of congenital syphilis has also increased by more than 900 percent. […] Routine STI screening of patients with HIV in order to reduce the spread of STIs is warranted, particularly because STIs, in turn, can increase HIV transmission. […] Individuals seeking an STI evaluation often do so because of a specific exposure. In such cases, we screen for the following infections: gonorrhea, chlamydia, syphilis, HIV, and Trichomonas. […] The optimal interval for screening of STIs is uncertain. For individuals with prior negative screening tests, the interval for re-evaluation will be influenced by persistence or change in risk factor profile. Positive screening tests are a marker for risk and warrant more frequent testing.
  • #29 Screening for sexually transmitted infections – UpToDate
    https://www.uptodate.com/contents/screening-for-sexually-transmitted-infections/print
    Screening for sexually transmitted infections (STIs) are a major public health problem in both resource-rich and limited settings. The immediate goal of screening for STIs is to identify and treat infected persons before they develop complications and to identify, test, and treat their sex partners to prevent transmission and reinfections. […] Complications of untreated sexually transmitted infections (STIs) include upper genital tract infections, infertility, chronic pelvic pain, cervical cancer, and chronic infection with hepatitis viruses and HIV. The approach to STI diagnosis and management is based upon disease or symptom-specific syndromes, including vaginal discharge, urethral discharge, ulcerative genital disease, nonulcerative genital disease, and pelvic pain. […] Routine screening for all potential STIs in all patients is cost-prohibitive; targeted screening of asymptomatic patients in specified risk groups is more feasible.
  • #30 The Rise of Sexually Transmitted Diseases and the Growing STD Diagnostics Market | Meridian Bioscience
    https://www.meridianbioscience.com/lifescience-blog/the-rise-of-sexually-transmitted-diseases-and-the-growing-std-diagnostics-market/
    More than one million sexually transmitted diseases and infections (STDs and STIs) are acquired every day worldwide and eight pathogens are responsible for the majority of them: human immunodeficiency virus (HIV), hepatitis B (HBV), herpes simplex virus (HSV), human papillomavirus (HPV), syphilis, gonorrhea, chlamydia and trichomoniasis. […] Preventing the spread of sexually transmitted diseases has been the cornerstone of public health efforts for decades. […] In response to the rise of STDs, more products for STD testing, in particular HIV testing, are entering the market and new tools are being introduced that make testing easier and more accessible. […] Overall, the STD diagnostics market will significantly evolve over the next decade in response to the complex challenges posed by the rising rates of sexually transmitted diseases.
  • #30 The Rise of Sexually Transmitted Diseases and the Growing STD Diagnostics Market | Meridian Bioscience
    https://www.meridianbioscience.com/lifescience-blog/the-rise-of-sexually-transmitted-diseases-and-the-growing-std-diagnostics-market/
    Another major shift is a move towards more molecular diagnostics for the diagnosis of STDs. […] Advances in technology, coupled with increased awareness and innovative testing approaches, are pivotal in shaping a future where early detection and intervention can effectively mitigate the impact of STDs. […] Driven by targets set by the World Health Organization (WHO) to end the STD epidemic as a major public health concern, more collaborative efforts will be needed between healthcare providers, policymakers, and the private sector in order to create a comprehensive and accessible sexual health ecosystem.
  • #31 Sexually Transmitted Diseases (STD) Diagnostics Market Size to 2034
    https://www.transparencymarketresearch.com/sexually-transmitted-disease-diagnostic.html
    Point-of-care (POC) diagnostic tests are the market leader in sexually transmitted diseases (STD) diagnosis. POC tests offer several advantages that include rapid results, ease of use, and the ability to perform outside of traditional laboratory settings, making them highly valuable in the field. […] Major players such as BD, Qiagen Diagnostics and Roche Diagnostics in the STD diagnostics market have focused on developing POC tests. […] According to the sexually transmitted diseases (STD) diagnostics market analysis, the diagnostic laboratories segment is likely to dominate based on end-user. Diagnostic laboratories have access to the newest and most advanced diagnostic technologies. […] These technologies help them to perform an extensive range of tests with high accuracy, including molecular tests, immunoassays, and point-of-care tests, which is vital to manage public health and control the spread of STDs.
  • #31 Sexually Transmitted Diseases (STD) Diagnostics Market Size to 2034
    https://www.transparencymarketresearch.com/sexually-transmitted-disease-diagnostic.html
    The global industry was valued at US$ 7.1 Bn in 2023. It is projected to grow at a CAGR of 7.6% from 2024 to 2034 and reach more than US$ 15.9 Bn by the end of 2034. […] Increase in prevalence and incidence of sexually transmitted diseases (STDs) globally is anticipated to be a key driver of the market. […] Companies operating in this market have come up with advanced diagnostic products for early detection of sexually transmitted infections. […] Despite numerous initiatives undertaken by government bodies and private organizations, the awareness or diagnosis rate of sexually transmitted disease is limited at the ground level. This is likely to be a restraining factor in the STD diagnostics market during the forecast period. […] Majorly, four types of diagnostic testing are used in sexually transmitted disease. Molecular test, serological test, point of care testing, and others that include immunological testing are used to detect Chlamydia, Gonorrhea, Syphilis, HIV, and other STD diseases. Point of care testing is the predominant test type for detection and diagnosis of STDs.
  • #32 STD Panel Test | Standard STI Panel Test (4) | Quest®
    https://www.questhealth.com/product/std-screening-panel-basic-37327M.html?srsltid=AfmBOooAyLDhFgBQjpfAVZ7PsEbuCaCUq3iPkLSvQZxNc38dYkKicmJr
    If your results indicate possible infection, you will receive an alert call from an independent healthcare coordinator. […] Independent physicians are available to discuss questions or concerns you may have regarding your results. […] Testing is key and treatment should be started as early as possible. […] Disease progression can be slowed with treatment. […] It is not always possible to know if you have an STD because many people do not have symptoms. […] Testing is the only way to know for sure if you have a sexually transmitted infection. […] Anyone who is sexually active should get tested at least once a year. […] The Centers for Disease Control and Prevention (CDC) makes the following STD annual screening recommendations, even in the absence of symptoms. […] According to the CDC, by following step-by-step collection instructions, patients can collect their own samples correctly, and the results of the tests are as accurate as when they are collected by a doctor. […] If you are pregnant, it is important to get tested for STDs as soon as possible and contact your OBGYN if you test positive for an STD for next steps.
  • #32 STD Panel Test | Standard STI Panel Test (4) | Quest®
    https://www.questhealth.com/product/std-screening-panel-basic-37327M.html?srsltid=AfmBOooAyLDhFgBQjpfAVZ7PsEbuCaCUq3iPkLSvQZxNc38dYkKicmJr
    This STD panel test screens for four of the most common sexually transmitted infections and diseases: chlamydia, gonorrhea, syphilis, and HIV 1 2. […] If your test results are abnormal, an independent physician may be able to provide treatment options at no extra cost. […] Sexually transmitted diseases (STDs) are common infections that spread from person to person during sexual activity and skin-to-skin contact. […] Individuals with STDs may not experience any signs or symptoms, and this can lead to serious health complications. […] If you’re sexually active and have unprotected sex, STD screening panels offer a convenient pathway to early detection and effective treatment. […] Treatment options may be available after your test if your results are positive or abnormal. […] After you provide your specimen, it generally takes a few business days to process and release your test results.
  • #33 Full Panel STD Test | Full STI Panel Test (7) | Quest®
    https://www.questhealth.com/product-std-screening-panel-expanded-37328M.html?srsltid=AfmBOorrUbSfxukiWVY-KgbBo5ZWtyczEG0Ekxm25DUcMNfs-4hIa9vM
    Screen for seven of the most common sexually transmitted infections and diseases, including chlamydia, gonorrhea, hepatitis B, hepatitis C, trichomoniasis, syphilis, HIV-1, and HIV-2, and take control of your sexual health. […] Treatment options may be available after your test if your results are positive or abnormal. […] Sexually transmitted diseases (STDs) are common infections that spread from person to person during sexual activity and skin-to-skin contact. […] If youre sexually active and have unprotected sex, its important to screen for STIs/STDs, so you can stay informed about your sexual health. […] This panel screens for chlamydia, gonorrhea, hepatitis B, hepatitis C, trichomoniasis, syphilis, HIV-1, and HIV-2. […] There are many treatments for sexually transmitted infections and diseases. Testing is key and treatment should be started as early as possible.
  • #34 Analysis of Sexually Transmitted Diseases ETS – THIS
    https://thismedical.com/en/std-test/
    STDs are asymptomatic, which increases the risk of transmitting any of the more than 20 types of Sexually Transmitted Diseases that currently exist. […] From This we know that early detection is crucial to treat STDs. For that reason, in our associated center you can get a specific analysis to detect STDs. […] To detect STDs it is enough to perform a blood and urine test, in addition to analysing the appropriate gynaecological samples. […] Our associated center has an analytical profile that analyses seven pathogens that are transmitted during sexual intercourse through molecular biology. These pathogens are: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma parvum, Ureaplasma urealyticum and Trichomonas vaginalis in urine. To this we can add the possibility to detect HIV and syphilis in a blood sample.
  • #35 Sexually Transmitted Diseases (STDs) – AL BORG DIAGNOSTICS
    https://alborgdx.com/ksa/en/sexually_transmitted_diseases/
    You can perform testing for each type of disease individually or choose programs that help detect most of these types. You can obtain a comprehensive STIs package at any branch of Al-Borg Diagnostics. This package lets you see STIs caused by over 30 different bacteria, viruses, and parasites. […] It is essential to mention that fasting is not required for the examination, meaning you can undergo it at any time of the day at an affordable price of only 799 Saudi Riyals.
  • #36 A Complete Guide to Blood Tests for STDs – STELLA MATTINA LLC
    https://stellamattina.com/a-complete-guide-to-blood-tests-for-stds/
    However, not all STDs will show up through a simple blood draw. […] A full STD blood panel typically consists of a comprehensive set of tests designed to detect a range of sexually transmitted infections (STIs) through blood samples. […] Blood STI testing can be highly accurate when used appropriately and interpreted with other clinical information. […] However, its essential to consider the limitations of STI testing, including the potential for false-negative and false-positive results. […] Regular STD testing is essential for disease control. […] The Centers for Disease Control and Prevention (CDC) recommends routine STD screening based on individual risk factors. […] The CDC provides guidelines for STD tests based on individual risk factors, including sexual behaviors, age, and medical history.
  • #36 A Complete Guide to Blood Tests for STDs – STELLA MATTINA LLC
    https://stellamattina.com/a-complete-guide-to-blood-tests-for-stds/
    If you have concerns about delays in receiving test results or the need for additional testing, you should communicate openly with your doctor. […] Receiving positive test results from STD testing can evoke a range of emotions. […] However, its essential to prioritize self-care, seek support, and engage in open and honest communication with your sexual partners. […] The general rule is that the earlier you get diagnosed and receive treatment, the better the outcomes.
  • #37 About Sexually Transmitted Infections (STIs) | STI | CDC
    https://www.cdc.gov/sti/about/index.html
    Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), are very common. […] The primary goal of public health and healthcare is to prevent and treat infections before they develop into disease. […] Therefore, it is possible to have an infection and not know it. That is why getting an STI test is important if you are having sex. If you receive a positive STI diagnosis, know that all are treatable with medicine and some are curable entirely. […] STIs pass from one person to another through vaginal, oral, and anal sex. […] STIs are common. Many are curable – all are preventable.
  • #38
    https://journals.lww.com/stdjournal/fulltext/2020/02000/testing_for_sexually_transmitted_diseases_in_us.9.aspx
    The increase in laboratory testing of TV may reflect the increased recognition of the importance of this neglected pathogen. […] Appropriate testing practices for STDs are critical to efforts to control and prevent these diseases. Testing patterns can also affect our ability to monitor trends in the prevalence of STDs. […] Future surveys are needed to continue to monitor and evaluate STD testing in PHLs and to identify changes in testing patterns. Testing practices could affect the resources available for STD screening and surveillance, and thus, it is important to monitor these practices and the capacity of PHLs to appropriately test for STDs.
  • #38
    https://journals.lww.com/stdjournal/fulltext/2020/02000/testing_for_sexually_transmitted_diseases_in_us.9.aspx
    The Association of Public Health Laboratories (APHL) surveyed local and state public health laboratories (PHLs) across the United States about the type and volume of tests being used to detect STDs. […] The purposes of this analysis are to describe the types and volume of laboratory tests for CT, GC, Treponema pallidum (syphilis), Trichomonas vaginalis (TV), herpes simplex virus (HSV), and human papillomavirus (HPV) conducted in PHLs in the United States in 2016 and to examine their alignment with current CDC laboratory testing guidelines. […] Public health laboratory testing practices were mostly aligned with CDC guidelines. […] Most PHLs continued to perform syphilis testing. Public health laboratory capacity to provide access to syphilis testing is very important, particularly given their critical role in providing follow-up nontreponemal and confirmatory testing for treponemal positive persons, especially those identified in outbreak responses.
  • #39 Sexually Transmitted Disease (STD) | Florida Department of Health in Miami-Dade
    https://miamidade.floridahealth.gov/programs-and-services/infectious-disease-services/std/index.html
    The Sexually Transmitted Disease (STD) Prevention and Control Program works to reduce the incidence of sexually transmitted diseases. By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against sexually transmitted diseases one person at a time. […] Surveillance is responsible for verifying the diagnosis and treatment of all reportable STDs from public and private health care providers. Private and public hospitals, laboratories, physicians and other health care providers are required by law to report positive STDs such as chlamydia, gonorrhea, and syphilis to the FDOH-Miami within 24 hours of positive results. […] Field services are a link between clinic services and persons who are either infected and/or at risk of acquiring a sexually transmitted disease. The STD field staff serves as the front line of defense for intervening in the spread of STDs. […] Partner Services are an integral component of Field Services. Partners should be informed if they have been exposed to HIV, syphilis or any other STDs. The STD Program staff can assist you in informing your partner(s) to get tested and/or treatment.
  • #40 Overview of Sexually Transmitted Infections – Infectious Diseases – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/infectious-diseases/sexually-transmitted-infections-stis/overview-of-sexually-transmitted-infections
    Most STIs can be effectively treated with antimicrobial medications. However, drug resistance is an increasing problem. […] Patients who are being treated for a bacterial STI should abstain from sexual intercourse until the infection has been eliminated from them and their sex partners. […] STI control depends on education of health care practitioners and the public, avoidance of high-risk behaviors by patients, adequate access to facilities and trained personnel for diagnosis and treatment, public health programs for locating and treating recent sex partners of patients, and follow-up for treated patients to ensure that they have been cured.
  • #41 Sexually Transmitted Infections Diseases | MicroGen Diagnostics
    https://microgendx.com/patients/sexually-transmitted-infections-diseases-std-sti/
    In contrast to a standard culture, a MicroGenDX test detects the DNA of all microbes in your sample, along with how much of each is present, and uses that information to identify the bacteria in your infection and the drugs that can best treat it. […] Your doctor should consult the „antimicrobials for consideration” chart on your MicroGenDX report to decide what antibiotic is right for you. […] For most STDs, you will provide a urine sample or a swab sample, sometimes both. Its very important to obtain a proper sample by following the instructions for collecting the sample, as well as when packaging and shipping it. […] An STD can be treated by a primary care physician or infectious disease specialist. Depending on the infection, it can also be treated by a urologist or an OB/GYN. […] If an STD is caused by a bacterial infection, it will be treated by one or more antibiotics. If the STD is caused by a fungus (yeast infection), it may be treated with antibiotics or an antifungal topical cream or ointment. If it is caused by a virus, one or more different types of drugs may be tried.
  • #42 Types of STI tests – Fraser Health AuthorityTypes of STI tests – Fraser Health Authority
    https://www.fraserhealth.ca/health-topics-a-to-z/sexual-health/get-tested-for-stis/types-of-sti-tests
    Sexually transmitted infections (STIs) are very common and often people don’t have obvious symptoms once infection occurs. Getting tested ensures prompt treatment for a positive result which can prevent serious health issues from developing. […] The good news is most STIs are treatable and many are curable. […] STI testing involves visiting a health care provider and/or a health clinic. In BC there are online options for STI testing. For more information go to GetChecked Online to see if this is available in your community. […] Blood, urine samples and sometimes swabs may be taken for STI testing. The visit may also involve a physical examination for symptoms. […] A health professional can advise you about what test you should get. […] In B.C., syphilis, gonorrhea, chlamydia, HIV, Hepatitis A, B and C are reportable STIs. This means that when lab tests for these infections are positive, results are reported to the local medical health officer (public health) to help prevent further transmission in the community. This information is stored securely and kept confidential.
  • #43 STD Diagnostics Market Size & Share | Industry Report, 2030
    https://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market
    Companies are broadening their STD diagnostics portfolios by adding multiplex testing kits, home-testing solutions, and AI-enabled digital health platforms. […] The HIV segment dominated the market with a share of 32.24% in 2024 and is anticipated to witness the fastest growth at a CAGR over the forecast period, owing to high testing rates, increased product approvals, such as fourth-generation HIV tests self-testing kits, and significant RD initiatives relevant to novel products. […] The immunoassay segment dominated the market in 2024 with a revenue share of 44.37%, owing to higher testing rates for Sexually Transmitted Disease (STD) diagnostics. […] The molecular diagnostics segment is expected to exhibit the fastest growth rate over the forecast period. An increase in the use of high-throughput PCR technology to detect Sexually Transmitted Diseases (STDs) is expected to drive the NAAT segment.